Growth & Syndromes P1

hrp0089p1-p159 | Growth & Syndromes P1

Does X-Chromosome Gene Dosage Determine Growth and Phenotypic Features in Turner Syndrome with 45,X/46,XX Mosaicism on Standard Karyotyping? A Cross-Sectional Analysis of the French National Rare Disease Network Database

hrp0089p1-p160 | Growth & Syndromes P1

Abstract unavailable

hrp0089p1-p161 | Growth & Syndromes P1

Analysis of Osteoblats Precursors in Girls with Turner Syndrome

hrp0089p1-p162 | Growth & Syndromes P1

Comparing the Cumulative Dose of Growth Hormone Therapy Using Body Weight-Based Dosing Versus Body Surface Area-Based Dosing in Children with Turner Syndrome – Data from the ANSWER Study

hrp0089p1-p163 | Growth & Syndromes P1

The Association between Growth Hormone Dose and Short-Term Height Outcomes in a Large Cohort of Paediatric Patients with Turner Syndrome: Real-World Data from the NordiNet^® International Outcome Study (IOS) and ANSWER Program

hrp0089p1-p164 | Growth & Syndromes P1

Changing Patterns of Growth in Prader-Willi Syndrome

hrp0089p1-p165 | Growth & Syndromes P1

Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in relation to Growth Hormone Therapy Onset

hrp0089p1-p166 | Growth & Syndromes P1

Safety and Effectiveness of Growth Hormone Treatment in Patients with Prader-Willi Syndrome under 2 Years of Age in a Reference Hospital

hrp0089p1-p167 | Growth & Syndromes P1

Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children with Prader-Willi Syndrome

hrp0089p1-p168 | Growth & Syndromes P1

GH Response to GHRH and Arginine in Previously GH-Treated Young Adults with Prader-Willi Syndrome

hrp0089p1-p169 | Growth & Syndromes P1

A Novel Type of Pubertal Height, Weight, and BMI Reference, Aligned for Onset of Puberty

hrp0089p1-p170 | Growth & Syndromes P1

Evaluating Cut-offs for Automatic Growth Screening in Swedish Children – Using the Finnish Growth Monitoring Algorithm

hrp0089p1-p171 | Growth & Syndromes P1

Prospective Study of Growth in Swedish Children Treated with Modified Ketogenic Diet

hrp0089p1-p172 | Growth & Syndromes P1

Early Gut Microbiota and childhood Growth

hrp0089p1-p173 | Growth & Syndromes P1

Clinical and Radiological Manifestations in a Large Swedish Family with a Pathogenic Heterozygous ACAN Variant

hrp0089p1-p174 | Growth & Syndromes P1

Identification of ADAMTS6 as a Novel Candidate Gene for Idiopathic Short Stature with Advanced Bone Maturation

hrp0089p1-p175 | Growth & Syndromes P1

Dual Function of the Retinoic Acid Catabolizing Enzyme CYP26C1 – Underlying Idiopathic Short Stature and Modifying Disease Severity in SHOX Deficiency

hrp0089p1-p176 | Growth & Syndromes P1

Growth Plate Disorders are the Main Cause of Severe Familiar Short Stature in Children Classified and Treated with Growth Hormone as SGA or GHD

hrp0089p1-p177 | Growth & Syndromes P1

Genetic Investigation of Children with Syndromic Prenatal Onset Short Stature

hrp0089p1-p178 | Growth & Syndromes P1

Identification of Three Novel Mutations in 10 Pediatric Patients with Unexplained Syndromic Short Stature Identified by Targeted Exome Sequencing in Korea

hrp0089p1-p179 | Growth & Syndromes P1

Beckwith Wiedemann Syndrome: First International Consensus Regarding Diagnosis and Clinical Management

hrp0089p1-p180 | Growth & Syndromes P1

Silver Russell and Beckwith-Wiedemann Syndromes: Mosaic Distribution of Epigenetic Anomalies

hrp0089p1-p181 | Growth & Syndromes P1

Long Term Effects of Childhood Growth Hormone Treatment on Height and Body Mass Index in Adolescents and Adults with Silver-Russell Syndrome

hrp0089p1-p182 | Growth & Syndromes P1

Year-one Effectiveness and Overall Safety of NutropinAq^® for Growth Hormone Deficiency (GHD) and Other Paediatric Growth Disorders: Completion of the International Cooperative Growth Study (iNCGS) European Registry

hrp0089p1-p183 | Growth & Syndromes P1

Carriers of IGF1-receptor Mutations As A Subgroup of SGA Patients: A Comprehensive Retrospective Comparison of Response to rhGH Treatment and Health Profile

hrp0089p1-p184 | Growth & Syndromes P1

Characteristics, Effectiveness and Safety Data for Patients with Growth Failure Treated with Recombinant IGF-I (rhIGF-I) and Achieving Adult or Near-adult Height (AH): Results from the European Increlex^® Growth Forum Database (EU-IGFD) Registry

hrp0089p1-p185 | Growth & Syndromes P1

Growth Outcome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-releasing Hormone Agonist

hrp0089p1-p186 | Growth & Syndromes P1

Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Six Patients

hrp0089p1-p187 | Growth & Syndromes P1

A Novel Deadly Variant in the TP53 Gene Causing Li-Fraumeni Syndrome. The Importance of Clinical Awareness and the Contribution of Molecular Diagnosis in Active Prevention Within Families with Multiple Tumor Incidents at a Young Age

hrp0089p1-p188 | Growth & Syndromes P1

ESPE Abstracts

57th Annual ESPE (ESPE 2018)

Poster Presentations

Does X-Chromosome Gene Dosage Determine Growth and Phenotypic Features in Turner Syndrome with 45,X/46,XX Mosaicism on Standard Karyotyping? A Cross-Sectional Analysis of the French National Rare Disease Network Database

Abstract unavailable

Analysis of Osteoblats Precursors in Girls with Turner Syndrome

Comparing the Cumulative Dose of Growth Hormone Therapy Using Body Weight-Based Dosing Versus Body Surface Area-Based Dosing in Children with Turner Syndrome – Data from the ANSWER Study

The Association between Growth Hormone Dose and Short-Term Height Outcomes in a Large Cohort of Paediatric Patients with Turner Syndrome: Real-World Data from the NordiNet^® International Outcome Study (IOS) and ANSWER Program

Changing Patterns of Growth in Prader-Willi Syndrome

Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in relation to Growth Hormone Therapy Onset

Safety and Effectiveness of Growth Hormone Treatment in Patients with Prader-Willi Syndrome under 2 Years of Age in a Reference Hospital

Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children with Prader-Willi Syndrome

GH Response to GHRH and Arginine in Previously GH-Treated Young Adults with Prader-Willi Syndrome

A Novel Type of Pubertal Height, Weight, and BMI Reference, Aligned for Onset of Puberty

Evaluating Cut-offs for Automatic Growth Screening in Swedish Children – Using the Finnish Growth Monitoring Algorithm

Prospective Study of Growth in Swedish Children Treated with Modified Ketogenic Diet

Early Gut Microbiota and childhood Growth

Clinical and Radiological Manifestations in a Large Swedish Family with a Pathogenic Heterozygous ACAN Variant

Identification of ADAMTS6 as a Novel Candidate Gene for Idiopathic Short Stature with Advanced Bone Maturation

Dual Function of the Retinoic Acid Catabolizing Enzyme CYP26C1 – Underlying Idiopathic Short Stature and Modifying Disease Severity in SHOX Deficiency

Growth Plate Disorders are the Main Cause of Severe Familiar Short Stature in Children Classified and Treated with Growth Hormone as SGA or GHD

Genetic Investigation of Children with Syndromic Prenatal Onset Short Stature

Identification of Three Novel Mutations in 10 Pediatric Patients with Unexplained Syndromic Short Stature Identified by Targeted Exome Sequencing in Korea

Beckwith Wiedemann Syndrome: First International Consensus Regarding Diagnosis and Clinical Management

Silver Russell and Beckwith-Wiedemann Syndromes: Mosaic Distribution of Epigenetic Anomalies

Long Term Effects of Childhood Growth Hormone Treatment on Height and Body Mass Index in Adolescents and Adults with Silver-Russell Syndrome

Year-one Effectiveness and Overall Safety of NutropinAq^® for Growth Hormone Deficiency (GHD) and Other Paediatric Growth Disorders: Completion of the International Cooperative Growth Study (iNCGS) European Registry

Carriers of IGF1-receptor Mutations As A Subgroup of SGA Patients: A Comprehensive Retrospective Comparison of Response to rhGH Treatment and Health Profile

Characteristics, Effectiveness and Safety Data for Patients with Growth Failure Treated with Recombinant IGF-I (rhIGF-I) and Achieving Adult or Near-adult Height (AH): Results from the European Increlex^® Growth Forum Database (EU-IGFD) Registry

Growth Outcome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-releasing Hormone Agonist

Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Six Patients

A Novel Deadly Variant in the TP53 Gene Causing Li-Fraumeni Syndrome. The Importance of Clinical Awareness and the Contribution of Molecular Diagnosis in Active Prevention Within Families with Multiple Tumor Incidents at a Young Age

Mutations in SHOX, GHR and IGFALS Genes Among Indian Children with ‘Idiopathic Short Stature’

BiosciAbstracts

ESPE Abstracts

57th Annual ESPE (ESPE 2018)

Growth &amp; Syndromes P1

Abstract unavailable

BiosciAbstracts

Growth & Syndromes P1